130 related articles for article (PubMed ID: 38936518)
41. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
[TBL] [Abstract][Full Text] [Related]
42. Disruption of cellular iron homeostasis by
Maio N; Saneto RP; Steet R; Sotero de Menezes MA; Skinner C; Rouault TA
Brain Commun; 2022; 4(3):fcac102. PubMed ID: 35602653
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial ferritin suppresses MPTP-induced cell damage by regulating iron metabolism and attenuating oxidative stress.
You LH; Li Z; Duan XL; Zhao BL; Chang YZ; Shi ZH
Brain Res; 2016 Jul; 1642():33-42. PubMed ID: 27017962
[TBL] [Abstract][Full Text] [Related]
44. Ferritinophagy-Mediated Ferroptosis Involved in Paraquat-Induced Neurotoxicity of Dopaminergic Neurons: Implication for Neurotoxicity in PD.
Zuo Y; Xie J; Li X; Li Y; Thirupathi A; Zhang J; Yu P; Gao G; Chang Y; Shi Z
Oxid Med Cell Longev; 2021; 2021():9961628. PubMed ID: 34394837
[TBL] [Abstract][Full Text] [Related]
45. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
46. Lactoferrin protects against iron dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease in mice.
Liu H; Wu H; Zhu N; Xu Z; Wang Y; Qu Y; Wang J
J Neurochem; 2020 Feb; 152(3):397-415. PubMed ID: 31442326
[TBL] [Abstract][Full Text] [Related]
47. Neurotrophic Role of the Next-Generation Probiotic Strain
Yue M; Wei J; Chen W; Hong D; Chen T; Fang X
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432569
[TBL] [Abstract][Full Text] [Related]
48. Multiple, conserved iron-responsive elements in the 3'-untranslated region of transferrin receptor mRNA enhance binding of iron regulatory protein 2.
Erlitzki R; Long JC; Theil EC
J Biol Chem; 2002 Nov; 277(45):42579-87. PubMed ID: 12200453
[TBL] [Abstract][Full Text] [Related]
49. The IRP/IRE system in vivo: insights from mouse models.
Wilkinson N; Pantopoulos K
Front Pharmacol; 2014; 5():176. PubMed ID: 25120486
[TBL] [Abstract][Full Text] [Related]
50. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway.
Chu B; Kon N; Chen D; Li T; Liu T; Jiang L; Song S; Tavana O; Gu W
Nat Cell Biol; 2019 May; 21(5):579-591. PubMed ID: 30962574
[TBL] [Abstract][Full Text] [Related]
51. Chemically Induced Models of Parkinson's Disease: History and Perspectives for the Involvement of Ferroptosis.
Wen S; Aki T; Unuma K; Uemura K
Front Cell Neurosci; 2020; 14():581191. PubMed ID: 33424553
[TBL] [Abstract][Full Text] [Related]
52. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
53. Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson's disease.
You LH; Li F; Wang L; Zhao SE; Wang SM; Zhang LL; Zhang LH; Duan XL; Yu P; Chang YZ
Neuroscience; 2015 Jan; 284():234-246. PubMed ID: 25301748
[TBL] [Abstract][Full Text] [Related]
54. Ferroptosis was more initial in cell death caused by iron overload and its underlying mechanism in Parkinson's disease.
Zhang P; Chen L; Zhao Q; Du X; Bi M; Li Y; Jiao Q; Jiang H
Free Radic Biol Med; 2020 May; 152():227-234. PubMed ID: 32217194
[TBL] [Abstract][Full Text] [Related]
55. New insights on neurodegeneration triggered by iron accumulation: Intersections with neutral lipid metabolism, ferroptosis, and motor impairment.
Maniscalchi A; Benzi Juncos ON; Conde MA; Funk MI; Fermento ME; Facchinetti MM; Curino AC; Uranga RM; Alza NP; Salvador GA
Redox Biol; 2024 May; 71():103074. PubMed ID: 38367511
[TBL] [Abstract][Full Text] [Related]
56. Excess capacity of the iron regulatory protein system.
Wang W; Di X; D'Agostino RB; Torti SV; Torti FM
J Biol Chem; 2007 Aug; 282(34):24650-9. PubMed ID: 17604281
[TBL] [Abstract][Full Text] [Related]
57. Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice.
Jeong SY; Crooks DR; Wilson-Ollivierre H; Ghosh MC; Sougrat R; Lee J; Cooperman S; Mitchell JB; Beaumont C; Rouault TA
PLoS One; 2011; 6(10):e25404. PubMed ID: 22003390
[TBL] [Abstract][Full Text] [Related]
58. Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.
Mahoney-Sánchez L; Bouchaoui H; Ayton S; Devos D; Duce JA; Devedjian JC
Prog Neurobiol; 2021 Jan; 196():101890. PubMed ID: 32726602
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro.
Li Q; Peng F; Yan X; Chen Y; Zhou J; Wu S; Jiang W; Jin X; Liang J; Peng C; Pan X
J Ethnopharmacol; 2023 Mar; 303():116029. PubMed ID: 36503029
[TBL] [Abstract][Full Text] [Related]
60. Ganoderic acid A mitigates dopaminergic neuron ferroptosis via inhibiting NCOA4-mediated ferritinophagy in Parkinson's disease mice.
Li QM; Wu SZ; Zha XQ; Zang DD; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Oct; 332():118363. PubMed ID: 38763373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
